Indication
Details coming soon
Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Tetanus, Diphtheria, and Pertussis Age: Adults Condition: Never received Tdap |
Dose: Injection – 1 dose Note: Followed by a Tetanus-diphtheria or Tdap booster every 10 years |
|
Indication: Inactivated Poliomyelitis Age: Adults Condition: Unvaccinated or incompletely vaccinated |
Dose: Injection – 3-dose primary series Frequency: at 0, 1–2, and 6–12 months |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Primary Immunization Age: Child |
Dose: Vaccination – 3 doses Frequency: given at an interval of 1-2 months Note: with booster 1 year after the primary vaccination around 16-18 months of age |
Administration
- Give intramuscularly
- Follow recommended schedule
Side Effect
- Pain
- erythema
- induration
- fever
- irritability
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
No interactions listed
|
-
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Progressive Encephalopathies
|
Risk of neurological deterioration
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.